Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1319-1322

  Chuang, Yin Ching ^a,b   Ko, Wen Chien ^a,b   Wang, Shan Tair ^b   Liu, Jien Wei ^a,c   Kuo, Chih Feng ^b   Wu, Jiunn Jong ^b   Huang, Kun Yen ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; MINOCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; GRAM NEGATIVE INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIBRIO VULNIFICUS;

EID: 0031860561     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1319     Document Type: Article

References (24)

1. Blake, P. A., M. H. Merson, R. E. Weaver, D. G. Hollis, and P. C. Heublein. 1979. Disease caused by a marine Vibrio: clinical characteristics and epidemiology. N. Engl. J. Med. 300:1-5.
2. Bonner, J. R., A. S. Coker, C. R. Berryman, and H. M. Pollock. 1983. Spectrum of vibrio infections in a Gulf Coast community. Ann. Intern. Med. 99:464-469.
3. Bowdre, J. H., J. H. Hull, and D. M. Cocchetto. 1983. Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline. J. Pharmacol. Exp. Ther. 225:595-598.
4. Chang, J. J., I. S. Sheen, S. M. Peng, P. C. Chen, C. S. Wu, and H. S. Leu. 1994. Vibrio vulnificus infection: report of 8 cases and review of cases in Taiwan. Chang. Gung. Med. J. 17:339-345.
5. Chuang, Y. C., C. Young, and C. W. Chen. 1989. Vibrio vulnificus infection. Scand. J. Infect. Dis. 21:721-726.
6. Chuang, Y. C., and C. D. Young. 1989. Vibrio vulnificus infection: clinical experience with 7 cases, abstr., p. 114-115. In Proceedings of the Formosan Medical Association Annual Meeting 1989. Formosan Medical Association, Taipei, Taiwan.
7. Chuang, Y. C. 1990. Vibrio vulnificus infection in Taiwan, p. 108. In Proceedings and abstracts of the 2nd Western Pacific Congress on Infectious Diseases and Chemotherapy. Infectious Diseases Association of Thailand and Western Pacific Society of Chemotherapy, Jomtien-Pattaya, Thailand.
8. Chuang, Y. C., C. Y. Yuan, C. Y. Liu, C. K. Lan, and A. H. M. Huang. 1992. Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin. Infect. Dis. 15:271-276.
9. Chuang, Y. C. 1992. Clin. Infect. Dis. 15:1072. (Letter.)
10. Chuang, Y. C., J. W. Liu, W. C. Ko, K. Y. Lin, J. J. Wu, and K. Y. Huang. 1997. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob. Agents Chemother. 41:2214-2217.
11. Chuang, Y. C., H. M. Sheu, W. C. Ko, T. M. Chang, M. C. Chang, and K. Y. Huang. 1997. Mouse skin damage caused by a recombinant extracellular metalloprotease from Vibrio vulnificus and by V. vulnificus infection. J. Formos. Med. Assoc. 96:677-684.
12. Fang, F. C. 1992. Use of tetracycline for treatment of Vibrio vulnificus infection. Clin. Infect. Dis. 15:1071-1072. (Letter.)
13. Freeman, G. H., and J. H. Halton. 1951. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 38:141-149.
14. Hsueh, P. R., J. C. Chang, S. C. Chang, S. W. Ho, and W. C. Hsieh. 1995. In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 14:151-153. (Letter.)
15. Kelly, M. T., and D. M. Avery. 1980. Lactose-positive Vibrio in seawater: a cause of pneumonia and septicemia in a drowning victim. J. Clin. Microbiol. 11:278-280.
16. Kelly, M. T., and W. F. McCormick. 1981. Acute bacterial myositis caused by Vibrio vulnificus. JAMA 246:72-73.
17. Klontz, K. C., S. Lieb, M. Schreiber, H. T. Janowski, L. M. Baldy, and R. A. Gunn. 1988. Syndromes of Vibrio vulnificus infections: clinical and epidemiologic features in Florida cases, 1981-1987. Ann. Intern. Med. 109:318-323.
18. Marascuilo, L. A., and M. McSweeney. 1977. Nonparametric and distribution-free methods for the social science. Brooks/Cole Company, Monterey, Calif.
19. Morris, J. G., Jr., and R. E. Black. 1985. Cholera and other vibrioses in the United States. N. Engl. J. Med. 312:343-350.
20. Morris, J. G., Jr., and J. Tenny. 1985. Antibiotic therapy for Vibrio vulnificus infection. JAMA 252:1221-1222. (Letter.)
21. Park, S. D., H. S. Shon, and N. J. Joh. 1991. Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J. Am. Acad. Dermatol. 24:397-403.
22. Poole, M. D., and J. D. Oliver. 1978. Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactosepositive Vibrio sp. Infect. Immun. 20:126-129.
23. Sanford, J. P., D. N. Gilbert, R. C. Moellering, Jr., and M. A. Sande. 1997. Selection of initial empirical antibacterial therapy on clinical grounds, p. 2-44. In J. P. Sanford, D. N. Gilbert, R. C. Moellering, Jr., and M. A. Sande (ed.), The Sanford guide to antimicrobial therapy, 27th ed. Antimicrobial Therapy Inc., Dallas, Tex.
24. Yuan, C. Y., C. C. Yuan, D. C. Wei, and A. M. Lee. 1987. Septicemia and gangrenous change of the legs caused by marine vibrio, Vibrio vulnificus - report of a case. J. Formos. Med. Assoc. 86:448-451.